Cardiopulmonary Stress Testing Systems Market
Cardiopulmonary Stress Testing Systems Market Study by CPET Systems, Stress ECG, Pulse Oximeters, SPECT, and Stress Blood Pressure Monitors from 2023 to 2033
Analysis of Cardiopulmonary Stress Testing Systems Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT4693MR
- 25 Jan 2023
- Healthcare
- 170 Pages
- 22 Tables
- 97 Figures
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Global Market Analysis and Forecasts, By Product Type
- 5.1. Cardiopulmonary Exercise Testing (CPET) Systems
- 5.2. Stress ECG
- 5.3. Pulse Oximeters
- 5.4. Stress Blood Pressure Monitors
- 5.5. Single-Photon Emission Computed Tomography (SPECT)
- 6. Global Market Analysis and Forecasts, By End-user
- 6.1. Hospitals
- 6.2. Specialty Clinics/Cardiology Clinics
- 6.3. Ambulatory Surgical Centers
- 6.4. Diagnostic Centers
- 7. Global Market Analysis and Forecasts, By Region
- 7.1. North America
- 7.2. Europe
- 7.3. Asia Pacific
- 7.4. Latin America
- 7.5. Middle East and Africa
- 8. North America Market Analysis and Forecast
- 9. Europe Market Analysis and Forecast
- 10. Asia Pacific Market Analysis and Forecast
- 11. Latin America Market Analysis and Forecast
- 12. Middle East and Africa Market Analysis and Forecast
- 13. Competition Landscape
- 13.1. Koninklijke Philips N.V.
- 13.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
- 13.3. General Electric Company (GE Healthcare)
- 13.4. MGC Diagnostics Corporation
- 13.5. OSI Systems, Inc. (Spacelabs Healthcare)
- 13.6. Masimo
- 13.7. NIHON KOHDEN CORPORATION
- 13.8. COSMED
- 13.9. Halma plc (SunTech Medical, Inc.)
- 13.10. Schiller AG
- 13.11. Vyaire Medical, Inc.
List Of Table
Table 01: Medical Device Classification as per U.S. FDA
Table 02: Code of Federal Regulations, by Type of Device
Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986 to 1997
Table 04: Medical Device Classification as per European Commission (EC)
Table 05: Global Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023 to 2033
Table 09: North America Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 10: North America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 12: Europe Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 13: Europe Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 17: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 18: Latin America Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 19: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 20: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033
Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033
Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033
Figure 02: Global Market Value Share, by Product (2022)
Figure 03: Global Market Value Share, by Region (2022)
Figure 04: Global Market Value Share, by End-user (2022)
Figure 05: FDA Review Process for 2022
Figure 06: Deaths per Mn Population Caused by Cardiovascular Diseases, by Country, 2012
Figure 07: Global Market Value Share, by Product Type, 2023 and 2033
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiopulmonary Exercise Testing (CPET) Systems, 2023 to 2033
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress ECG, 2023 to 2033
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulse Oximeters, 2023 to 2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress Blood Pressure Monitors, 2023 to 2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single-Photon Emission Computed Tomography (SPECT), 2023 to 2033
Figure 13: Global Market Attractiveness, by Product Type, 2023 to 2033
Figure 14: Global Market Value Share, by End-user, 2023 and 2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2023 to 2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics/ Cardiology Clinics, 2023 to 2033
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2023 to 2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2023 to 2033
Figure 19: Global Market Attractiveness, by End-user, 2023 to 2033
Figure 20: Global Market Value Share, by Region, 2023 and 2033
Figure 21: Global Market Attractiveness, by Region, 2023 to 2033
Figure 22: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033
Figure 23: North America Market Value Share, by Country, 2023 and 2033
Figure 24: North America Market Attractiveness, by Country, 2023 to 2033
Figure 25: North America Market Value Share, by Product Type, 2023 and 2033
Figure 26: North America Market Attractiveness, by Product Type, 2023 to 2033
Figure 27: North America Market Value Share, by End-user, 2023 and 2033
Figure 28: North America Market Attractiveness, by End-user, 2023 to 2033
Figure 29: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033
Figure 30: Europe Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 31: Europe Market Attractiveness, by Country/Sub-region, 2023 to 2033
Figure 32: Europe Market Value Share, by Product Type, 2023 and 2033
Figure 33: Europe Market Attractiveness, by Product Type, 2023 to 2033
Figure 34: Europe Market Value Share, by End-user, 2023 and 2033
Figure 35: Europe Market Attractiveness, by End-user, 2023 to 2033
Figure 36: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033
Figure 37: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 38: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023 to 2033
Figure 39: Asia Pacific Market Value Share, by Product Type, 2023 and 2033
Figure 40: Asia Pacific Market Attractiveness, by Product Type, 2023 to 2033
Figure 41: Asia Pacific Market Value Share, by End-user, 2023 and 2033
Figure 42: Asia Pacific Market Attractiveness, by End-user, 2023 to 2033
Figure 43: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033
Figure 44: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 45: Latin America Market Attractiveness, by Country/Sub-region, 2023 to 2033
Figure 46: Latin America Market Value Share, by Product Type, 2023 and 2033
Figure 47: Latin America Market Attractiveness, by Product Type, 2023 to 2033
Figure 48: Latin America Market Value Share, by End-user, 2023 and 2033
Figure 49: Latin America Market Attractiveness, by End-user, 2023 to 2033
Figure 50: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033
Figure 51: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 52: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023 to 2033
Figure 53: Middle East & Africa Market Value Share, by Product Type, 2023 and 2033
Figure 54: Middle East & Africa Market Attractiveness, by Product Type, 2023 to 2033
Figure 55: Middle East & Africa Market Value Share, by End-user, 2023 and 2033
Figure 56: Middle East & Africa Market Attractiveness, by End-user, 2023 to 2033
Figure 57: Global Market Share, by Company, 2022
Figure 58: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.
Figure 59: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.
Figure 60: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.
Figure 61: Breakdown of Net Sales (%), by Region, 2022, Koninklijke Philips N.V.
Figure 62: Breakdown of Net Sales (%), by Business Segment, 2022, Koninklijke Philips N.V.
Figure 63: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 64: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 65: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
Figure 66: Breakdown of Net Sales (%), by Region, 2022 (Hill-Rom Holdings, Inc.)
Figure 67: Breakdown of Net Sales (%), by Business Segment, 2022 (Hill-Rom Holdings, Inc.)
Figure 68: Breakdown of Net Sales (%), by Region, 2018 (Welch Allyn)
Figure 69: Breakdown of Net Sales (~ %), by Business Segments, 2022 (Mortara Instrument, Inc.)
Figure 70: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)
Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)
Figure 72: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)
Figure 73: Breakdown of Net Sales (%), by Region, 2022, General Electric Company (GE Healthcare)
Figure 74: Breakdown of Net Sales (%), by Business Segment, 2022, General Electric Company (GE Healthcare)
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation
Figure 76: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation
Figure 77: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation
Figure 78: Breakdown of Net Sales (%), by Region, 2022, MGC Diagnostics Corporation
Figure 79: Breakdown of Net Sales (%), by Business Segment, 2022, MGC Diagnostics Corporation
Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 81: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 82: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 83: Breakdown of Net Sales (%), by Region, 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 84: Breakdown of Net Sales (%), by Business Segment, 2022, OSI Systems, Inc. (Spacelabs Healthcare)
Figure 85: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo
Figure 86: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo
Figure 87: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo
Figure 88: Breakdown of Net Sales (%), by Region, 2022, Masimo
Figure 89: Installed Base (Estimated Units) and Y-o-Y Growth (%), 2018 to 2022, Masimo
Figure 90: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION
Figure 91: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION
Figure 92: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION
Figure 93: Breakdown of Net Sales (%), by Region, 2022, NIHON KOHDEN CORPORATION
Figure 94: Breakdown of Net Sales (%), by Business Segment, 2022, NIHON KOHDEN CORPORATION
Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Halma plc (SunTech Medical, Inc.)
Figure 96: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Halma plc (SunTech Medical, Inc.)
Figure 97: Breakdown of Net Sales (%), by Business Segment, 2022, Halma plc (SunTech Medical, Inc.)
Cardiopulmonary Stress Testing Systems Market